What’s at stake?
AI stalls when fragmented scientific content can't be interrogated at scale
When AI can’t scale across scientific content, bottlenecks emerge across the enterprise
Siloed literature and content pipelines slow AI-driven target discovery
Fragmented content limits AI-driven trial site mapping, recruitment insights, biomarker validation.
Disconnected content sources prevent scalable, consistent identification of true scientific influence.
Reliance on manual review extends cycle times and slows decision-making, especially as the volume of scientific evidence continues to grow.
Inconsistent AI-driven insight into competitive positioning, market access and customer segments limits commercial strategy.
A better way…
Imagine a “Scientific GPS”
that enables you to:
- Ask any scientific question
- Triangulate across 100s of millions of documents
- Gain high-precision navigation to defensible, evidence-backed answers – fast
Enter…
IQVIA AI Scientific Navigator
AI Scientific Navigator
AI-Ready Content Foundation + Easy Interrogation = Enterprise ROI
Discover how to get answers faster by interrogating over 315 million centralized documents, extensible to any other sources you need.
Watch the video at right to learn more.
AI Scientific Navigator
Core benefits to your business
AI SCIENTIFIC NAVIGATOR IN ACTION
Driving ROI for key use cases across life sciences and beyond
Discover how our customers are having a positive impact on patients and business.
R&D: Discovery Customer Examples
- Identify new indication opportunities
Biotech shaved 3 years from the average time for target identification to IND. - Find novel targets for disease areas
Top 10 pharma discovered 50% more biomarkers in Multiple Sclerosis. - Assess potential biomarkers for development
Top 10 pharma increased recall 10X for target intelligence from patents.
R&D: Clinical Customer Examples
- Boost CT design via understanding legacy trials
Top 10 pharma found CT efficacy data “previously difficult to find or unobtainable.” - Clinical outcomes of new therapies compared to SOC
Top 10 pharma achieved 10-12X faster extraction of clinical endpoints from CT.gov. - Find patient-centered endpoints
Top 10 pharma discovered novel patient-centric endpoints from social media.
R&D: Safety Customer Examples
- Landscape of safety events for drug products
Regulator found 3X more drugs (compared to manual) that needed black box warning. - Preclinical toxicity alerts for drug or drug class
Top 10 pharma’s natural language processing pipeline enabled effective assessment of safety findings for drugs in development from historical toxicity findings. - Evaluate and contextualize potential safety signal
Biotech achieved effective identification of patients at risk from complex adverse-event syndrome in near-real time.
R&D: Regulatory Customer Examples
- Updates on latest information in drug labels
Top 10 pharma achieved 20X reduction in drug label comparison time. - Understand regulatory updates to ensure compliance
Top 10 pharma used natural language processing pipeline to enable sustainable and scalable insights from external and internal regulatory sources. - Assess IP landscape to assist regulatory planning
Top 10 pharma enabled 7X FTE time saved and 99% efficiency gain for patent search.
Real World: HEOR Customer Examples
- Literature review for cost effectiveness and utility scores
Top 10 pharma used natural language processing pipeline for cancer outcomes for novel checkpoint therapies. - Understand patient reported outcomes from clinical studies
Top 10 pharma identified cancer survival metrics from CT.gov with reduced costs, time and errors. - Insights from comparative effectiveness studies
Top 10 pharma enabled alerts for comparator trials that provided the earliest, most complete picture of emerging clinical research.
AI SCIENTIFIC NAVIGATOR IN ACTION
More ROI use cases across life sciences and beyond
Continue to explore how our customers are having a positive impact on patients and business across life sciences and beyond.
Real World: Market Access Customer Examples
- Monitor Health Technology Assessment (HTA) websites for policy changes
Top 10 pharma achieved a structured summary (50 variables from ~400 HTA submissions) to enable strategy support of pipeline drugs. - Insights into cost / benefit of current SOC treaments
Top 10 pharma achieved 25X faster literature reviews for economic, humanistic and clinical burden which enabled agile insights for market access strategy.
Real World: Medical Affairs Customer Examples
- Develop patient outreach and support strategies
Top 10 pharma developed a comprehensive literature landscape for coeliac disease insights (symptoms, impacts, digital and non-digital therapeutics) to support patient initiatives. - Identifying emerging KOLs
Top 10 pharma identified the top five health care provider digital influencers in obesity. - Actionable insights from integrated “real world” data
Top 10 pharma developed an award-winning natural language processing pipeline for healthcare market trends from MIRs, MSL notes, news and literature for a novel drug.
Commercial: Brand & Marketing Examples
- Patient voice analytics for brand adherence
Top 10 pharma achieved 2X efficiency in trend analytics for voice of customer from call center feeds. - Tracking competitor claims across conferences and papers
Top 10 pharma achieved 5X time saved for competitive landscape of autoimmune disease emerging clinical intelligence. - Share of Scientific Voice (SoSV)
MedTech company gains SoSV metrics for their own and competitor brands – covering social, news, congress and literature – which enables effective response to evidence gaps.
Commercial: Sales Ops Customers Examples
- Identify high-performing healthcare providers from papers, trials
Top 10 pharma completed a targeted literature review for T2D and obesity in just 6 weeks (3,000 papers), with key healthcare provider characteristics. - Detect “hot spots” of emerging disease clusters
Top 50 pharma uses natural language processing for social media to provide rapid access to COVID-19 intelligence. - Insights from internal field sales notes
Top 50 pharma gains topics and trends from field notes to inform sales strategy.
Healthcare: Customers Examples
- Extracting insights from unstructured pathology notes
Kaiser Permanente achieves >95% accuracy in identifying Aortic Stenosis from 957,505 echo reports. - Proactively manage high risk patient populations
Northshore University HealthSystem closed care gaps by identifying and reaching out to 56% more at-risk patients based on Social Determinants of Health. Their deployment of IQVIA Scientific Navigator won the AI Breakthrough Award for Best AI-based Solution for Healthcare. - Deep phenotypes from genomic reports
University of Iowa achieved 3X deeper phenotyping with 90% accuracy in a fraction of the time it would take to complete the work manually.
Frequently Asked Questions
How AI Scientific Navigator helps you get defensible answers from complex scientific content
It is an AI-ready content foundation built on over 315 million centralized documents and extensible to any other sources you need. Powerful search, LLMs and agentic techniques make it easy to interrogate it all. It’s your fastest route to a defensible answer for virtually any scientific question.
Scientific databases provide access to valuable content, but they must be searched separately and rely largely on keyword-based retrieval. AI Scientific Navigator prepares and indexes scientific meaning across sources up front. That way terminology, evidence types and recency are normalized, enabling faster, more complete and defensible answers across the full scientific landscape.
AI Scientific Navigator supports a wide range of scientific and evidence-based questions across the drug life cycle from pharma R&D through Commercial. For specific examples please see the section above on Driving ROI for key use cases across life sciences and beyond.
AI Scientific Navigator’s content foundation begins with a selection of over 350 million documents all centralized into one secure environment. And because there is no limit to what you can add, it can grow to encompass your entire scientific content universe. You can easily augment public content sources with IQVIA-exclusive content, proprietary sources and your own private information. All this biomedical, regulatory and scientific content is continuously updated and indexed with rich ontologies (including medical synonyms) for high-precision interrogation through powerful search, LLMs and agentic techniques. For a closer look at available content sources watch our video AI-Ready Content Foundation + Easy Interrogation = Enterprise ROI.
AI Scientific Navigator helps organizations reduced duplicate work, gain consistent enterprise-wide use of AI and faster, more defensible scientific answers – without frustration. For specific ROI examples please see the section above on Driving ROI for key use cases across life sciences and beyond.
